NCT06329037View on ClinicalTrials.gov

The Effects of Oral Vasopressin on Attention Control: An Eye-tracking Study

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 5, 2024

Primary Completion Date

June 1, 2025

Study Completion Date

July 30, 2025

Conditions
Healthy
Interventions
DRUG

Vasopressin

Administration of Vasopressin (20 IU) (oral spray)

DRUG

Placebo

Administration of Placebo (oral spray)

Trial Locations (1)

611731

RECRUITING

University of Electronic Science and Technology of China, Chengdu

All Listed Sponsors
lead

University of Electronic Science and Technology of China

OTHER

NCT06329037 - The Effects of Oral Vasopressin on Attention Control: An Eye-tracking Study | Biotech Hunter | Biotech Hunter